The Magazine for Sleep Professionals
Sunday, April 26, 2026
Fisher & Paykel Healthcare has announced the United States launch of F&P Evora™ Full, a compact full-face mask for obstructive sleep apnea (OSA) treatment. The mask has received FDA 510(k) clearance, paving the way for its sale into the United States following its launch in Australia, New Zealand, Europe and […]
Pfizer Inc. announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or RSVpreF, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age or older. The FDA decision is primarily […]
Fisher & Paykel Healthcare Corporation Limited provided revenue guidance for the financial year ending 31 March 2022. At current exchange rates, the company expects full year operating revenue for the 2022 financial year to be in the range of $1.675 billion to $1.70 billion. Managing Director and Chief Executive Officer […]
With independent studies showing that 8 out of 10 people use their inhalers incorrectly1, inhaler technique training supports more accurate drug delivery, helping patients get the full benefit of their medication, and resulting in better disease management. The Vitalograph AIM™ (Aerosol Inhalation Monitor) is designed to assist medical practitioners in […]
On March 10th, the U.S. Food and Drug Administration issued a notification order to Philips Respironics requiring the company to notify patients and others of the company’s June 14, 2021, recall of certain Philips Respironics ventilators, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) machines, and the […]
A new study funded by the American Lung Association reveals that young adults who used e-cigarettes were more likely to develop respiratory issues within one year of vaping. The study, titled, “Association of Electronic Cigarette Use with Respiratory Symptom Development among US Young Adults,” will be published in the American Journal of Respiratory and Critical Care Medicine, one […]
Bleep, LLC. has been awarded a $1.7 million SBIR (Small Business Innovation Research) grant from the National Institutes of Health (NIH) to optimize positive airway pressure (PAP) mask design for use in home and acute care/hospital settings. Bleep, LLC hopes to add value in patient comfort and compliance with PAP […]
In its latest clinical practice guideline on evaluation and treatment of asthma, an American Thoracic Society expert guidelines panel has addressed the use of fractional exhaled nitric oxide (FeNO) to guide the treatment of asthma. The guideline was published online in the Nov. 15 issue of the American Journal of Respiratory and Critical […]
The U.S. Food and Drug Administration is providing an update related to the June 14, 2021, recall of certain Philips Respironics ventilators, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) machines. “Ensuring patients and providers have the most up-to-date information regarding the recall of these critical devices […]
Congressman Jamie Raskin (MD) introduced a bipartisan resolution recognizing the significant contributions that respiratory therapists have made during the COVID-19 pandemic. The introduction of the bipartisan resolution falls during National Respiratory Care Week and demonstrates Congress’s continued support for the exceptional respiratory therapists who live and work in our communities. […]
